Nicotine is an addictive chemical. Content on this site is for informational purposes only and is not medical or legal advice. For adults 21+.

ZYN and Microplastics: What the FDA Controversy Is About

By PouchGuide Editorial Team · Published September 28, 2026

In July 2026, a former FDA scientist went public with a claim that got a lot of attention: the agency authorized ZYN without knowing exactly what the pouch is made of, and without assessing whether it could release microplastics. Here’s what’s been claimed, what the FDA said, and what it means for ZYN users.

What’s being claimed

According to reporting by STAT News (July 14, 2026):

What the FDA and PMI said

The FDA authorized 20 ZYN products for sale in January 2025, and granted them a modified-risk order in June 2026 (see our explainer).

What’s actually known about the health risk

This is the key point: no study has shown that ZYN pouches release microplastics into users’ bodies, or that they cause harm this way. What exists is:

So the honest status is: an open question the FDA didn’t formally assess, not a demonstrated harm. It would take proper testing of the pouch material, and of what it releases during realistic use, to answer it.

Why this matters

What you can do if you’re concerned

Bottom line

A former FDA toxicologist says the agency authorized ZYN without identifying the pouch material, which she believes resembles cigarette-filter cellulose acetate, or assessing microplastic release. The FDA says its review found no new concerns, but acknowledged it didn’t address microplastics. No study has shown ZYN pouches release microplastics into users or cause harm, so this is an open question, not an established risk. We’ll update this post if the FDA or independent researchers publish testing.

Sources

Related articles

All articles →